SGRY

Surgery Partners Inc

• TipRanks·05/14 10:48

  Bank of America Securities Remains a Buy on Surgery Partners (SGRY)

• TipRanks·05/13 11:21

  RBC Capital Sticks to Their Buy Rating for Surgery Partners (SGRY)

• TipRanks·05/13 08:50

  Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Sarepta Therapeutics (SRPT) and Surgery Partners (SGRY)

• Simply Wall St·05/10 12:24

  A Look At Surgery Partners (SGRY) Valuation After Reaffirmed Guidance And Positive First Quarter Results

• Simply Wall St·05/08 09:40

  Stronger Q1 Results And Reaffirmed Outlook Might Change The Case For Investing In Surgery Partners (SGRY)

• TipRanks·05/07 02:16

  Surgery Partners price target raised to $17 from $15 at Jefferies

• TipRanks·05/06 08:41

  Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), uniQure (QURE) and Surgery Partners (SGRY)

• Simply Wall St·05/06 00:54

  Surgery Partners (SGRY) Losses Of US$77.9 Million Keep Profitability Narrative Under Pressure

• TipRanks·05/06 00:33

  Surgery Partners Balances Growth Ambitions With Rising Headwinds

• Seeking Alpha·05/05 19:42

  Surgery Partners outlines 2026 revenue of $3.35B-$3.45B and adjusted EBITDA of at least $530M as portfolio optimization targets mid-2026 announcement

• TipRanks·05/05 16:02

  Midday Fly By: Palantir reports ‘beat and raise,’ Coinbase to cut staff

• Benzinga·05/05 13:43

  Surgery Partners Q1 2026 Earnings Call Transcript

• TipRanks·05/05 13:10

  Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Cardiol Therapeutics (CRDL) and Vertex Pharmaceuticals (VRTX)

• TipRanks·05/05 12:16

  Surgery Partners reports Q1 adjusted EPS (3c), consensus (14c)

• TipRanks·05/05 12:16

  Surgery Partners backs FY26 revenue view $3.35B-$3.45B, consensus $3.41B